Cargando…

Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010

BACKGROUND: The Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) is a global surveillance study of antimicrobial susceptibility. This study reports data from Gram-negative isolates collected from centers in Latin America between 2004 and 2010. METHODS: Consecutive bacterial isolates were tes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fernández-Canigia, Liliana, Dowzicky, Michael J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499165/ https://www.ncbi.nlm.nih.gov/pubmed/23088592 http://dx.doi.org/10.1186/1476-0711-11-29

Ejemplares similares

Changes in Staphylococcus aureus susceptibility across Latin America between 2004 and 2010
por: Garza-González, Elvira, et al.
Publicado: (2013)

The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016
por: Decousser, Jean-Winoc, et al.
Publicado: (2018)

Antimicrobial susceptibility among Gram-positive and Gram-negative organisms collected from the Latin American region between 2004 and 2015 as part of the Tigecycline Evaluation and Surveillance Trial
por: Vega, Silvio, et al.
Publicado: (2017)

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017)

Longitudinal Assessment of Antimicrobial Susceptibility among Gram-Negative and Gram-Positive Organisms Collected from Italy as Part of the Tigecycline Evaluation and Surveillance Trial between 2004 and 2011
por: Stefani, Stefania, et al.
Publicado: (2013)

A longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012
por: Cattoir, Vincent, et al.
Publicado: (2014)

Global in vitro activity of tigecycline and comparator agents: Tigecycline Evaluation and Surveillance Trial 2004–2013
por: Hoban, Daryl J, et al.
Publicado: (2015)

Assessment of the Activity of Tigecycline against Gram-Positive and Gram-Negative Organisms Collected from Italy between 2012 and 2014, as Part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Stefani, Stefania, et al.
Publicado: (2016)

Antimicrobial susceptibility among gram-negative isolates collected in the USA between 2005 and 2011 as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.)
por: Denys, Gerald A, et al.
Publicado: (2013)

Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial
por: Morfin-Otero, Rayo, et al.
Publicado: (2015)

Tigecycline Susceptibility Trends Among Pathogens Isolated from Complicated Skin and Soft-Tissue Infections in North and Latin America: 2012–2016
por: Hoban, Daryl, et al.
Publicado: (2017)

Regional and global antimicrobial susceptibility among isolates of Streptococcus pneumoniae and Haemophilus influenzae collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) from 2009 to 2012 and comparison with previous years of T.E.S.T. (2004-2008)
por: Tomic, Viktorija, et al.
Publicado: (2014)

Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial
por: Zhang, Zhijie, et al.
Publicado: (2018)

Mechanisms of Antibiotic Resistance in Important Gram-Positive and Gram-Negative Pathogens and Novel Antibiotic Solutions
por: Kakoullis, Loukas, et al.
Publicado: (2021)

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
por: Mabrouk, Samar S., et al.
Publicado: (2023)

Resistant Gram-negative infections in the outpatient setting in Latin America
por: SALLES, M. J. C., et al.
Publicado: (2013)

In vitro combination of tigecycline with other antibiotics in Stenotrophomonas maltophilia isolates
por: KARAMANLIOĞLU, Dilek, et al.
Publicado: (2019)

Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline
por: Babaei, Sima, et al.
Publicado: (2021)

Susceptibility of cefiderocol and other antibiotics against carbapenem-resistant, Gram-negative bacteria
por: Wang, Yifan, et al.
Publicado: (2022)

In vitro susceptibility of Campylobacter jejuni from Kuwait to tigecycline & other antimicrobial agents
por: Albert, M. John
Publicado: (2013)

Gram-Negative Infections in Adult Intensive Care Units of Latin America and the Caribbean
por: Luna, Carlos M., et al.
Publicado: (2014)

Patterns of influenza B circulation in Latin America and the Caribbean, 2010–2017
por: Palekar, Rakhee, et al.
Publicado: (2019)

Rheumatoid arthritis in Latin America: the importance of an early diagnosis
por: da Mota, Licia Maria Henrique, et al.
Publicado: (2015)

Rheumatoid arthritis in Latin America. Important challenges to be solved
por: Burgos Vargas, Ruben, et al.
Publicado: (2015)

Correlation between the Antibiotic Resistance Genes and Susceptibility to Antibiotics among the Carbapenem-Resistant Gram-Negative Pathogens
por: Abdelaziz, Salma M., et al.
Publicado: (2021)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Application of the McDonald criteria in Latin America
por: Patrucco, Liliana
Publicado: (2017)

A7.5 In Vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Asia - Tigecycline evaluation surveillance trial (T.E.S.T.)
Publicado: (2005)

The epidemiology of meningococcal disease in Latin America 1945–2010: an unpredictable and changing landscape
por: SÁFADI, M. A. P., et al.
Publicado: (2013)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Latin America /
por: Goodwin, Paul B., 1942-
Publicado: (2000)

Impact of Tigecycline Versus Other Antibiotics on the Fecal Metabolome and on Colonization Resistance to Clostridium difficile in Mice
por: Jump, Robin L.P., et al.
Publicado: (2017)

High-resolution gridded population datasets for Latin America and the Caribbean in 2010, 2015, and 2020
por: Sorichetta, Alessandro, et al.
Publicado: (2015)

Rotavirus G9P[4] in 3 Countries in Latin America, 2009–2010
por: Quaye, Osbourne, et al.
Publicado: (2013)

Endocarditis Caused by Gram-Negative Moraxella osloensis in an Immunocompetent Patient: First Case Report in Latin America
por: Paiva, Patricia Fraga, et al.
Publicado: (2018)

Current situation of allergy education in Mexico and other parts of Latin America()
por: Gonzalez-Diaz, Sandra Nora, et al.
Publicado: (2021)

The importance of integrons for development and propagation of resistance in Shigella: the case of Latin America
por: Barrantes, Kenia, et al.
Publicado: (2016)

Sepsis is an important healthcare burden in Latin America: a call to action!
por: Azevedo, Luciano Cesar Pontes, et al.
Publicado: (2018)

Importance of underweight in childhood bacterial meningitis in Finland, Latin America and Angola
por: Roine, Irmeli, et al.
Publicado: (2022)

Latin America : the politics of immobility
por: Adie, Robert F., 1936-
Publicado: (1974)

Cannot write session to /tmp/vufind_sessions/sess_4kgjtis38c29r63l4th50oi9ca